Samuel Huber

Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer

Victor G. Puelles, T. Renné, C. Bokemeyer, 2023, Nature.

Longitudinal single-cell data informs deterministic modelling of inflammatory bowel disease

M. Büttner, E. Villablanca, L. Adlung, 2023, bioRxiv.

IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction

B. Fehse, K. Riecken, Babett Steglich, 2023, Journal of hepatology.

Protocol for generating lung and liver metastasis in mice using models that bypass intravasation

Jöran Lücke, A. Giannou, D. Zazara, 2024, STAR protocols.

Targeting T cell plasticity in kidney and gut inflammation by pooled single-cell CRISPR screening

U. Panzer, B. Fehse, K. Riecken, 2024, Science Immunology.

IL-22 promotes liver regeneration after portal vein ligation

Jöran Lücke, A. Shiri, A. Giannou, 2024, Heliyon.

Pro- and antitumorigenic functions of γδ T cells.

Gina J. Fiala, Jöran Lücke, Samuel Huber, 2024, European journal of immunology.

E. coli´s fight against TYROnny: Designing a bacterial strain to tackle tyrosinemia type 1.

Jöran Lücke, Samuel Huber, 2023, Journal of hepatology.